Recent news on Insulin Glargine

Hypoglycemia: Answering the Challenge With Long-acting Insulin Analogs  -  May 18, 2007
Medscape (subscription)Insulin glargine: an updated review of its use in the management of diabetes mellitus. Drugs. 2003;63:1743-1778. Abstract

Intensive Glucose Control in Elderly Adults—Reply  -  May 22, 2007
Journal of American Medical Association (subscription),Riddle MC, Rosenstock J, Gerich J, Insulin Glargine 4002 Study Investigators. The treat-to-target trial: randomized addition of glargine or human NPH

New Prefilled Disposable Insulin Pen Approved  -  May 2, 2007
Facts and Comparisons,The FDA has approved Sanofi-Aventis’ Lantus SoloStar, a new prefilled, once-daily disposable insulin pen for Lantus (insulin glargine) for the treatment of

Good news for diabetic mums-to-be  -  Apr 25, 2007
Bounty,Researchers in the UK have declared that there is no discernable effect on babies whose mothers take insulin glargine - a man-made insulin - during

Insulin therapy for diabetes  -  May 16, 2007
Chennai Online,Long-acting insulins: Lilly’s Humulin U (ultralente), Sanofi-Aventis’ Lantus (insulin glargine), and Novo’s Levemir fall in this class.

FDA Approves Lantus SoloStar(R) - A New Prefilled Disposable ...  -  May 1, 2007
PR Newswire (press release),New Delivery Method Available for LANTUS(R) (insulin glargine [rDNA origin] injection) BRIDGEWATER, NJ, April 30 /PRNewswire-FirstCall/ -- Sanofi-aventis

Sopranos Star Aida Turturro Speaks out to Encourage Fellow ...  -  May 8, 2007
PR Newswire (press release),Then, about three years ago, we added Lantus (insulin glargine [rDNA origin] injection), a once-daily, long-acting insulin to my treatment plan.

FDA Approves Lantus SoloStar®  -  May 4, 2007
Diabetes Health (press release),...a new prefilled disposable insulin pen for once-daily 24-hour insulin LANTUS® (insulin glargine) for the treatment of hyperglycemia in people with type

Exenatide Similar to Insulin in Reducing Blood Glucose, but Also ...  -  26 Apr 2007
DG NewsExenatide was administered as a fixed 10 mcg dose BID, and insulin was titrated regularly and administered QD (insulin glargine) or BID (biphasic insulin

New injectable treatment for type II diabetes  -  26 Apr 2007
Healthcare RepublicThe efficacy of exenatide has also been compared to insulin glargine 4 and insulin aspart 5 in patients that are inadequately controlled with metformin and

Good news for diabetic mums-to-be  -  Apr 25, 2007
Bounty,Researchers in the UK have declared that there is no discernable effect on babies whose mothers take insulin glargine - a man-made insulin - during

Insulin glargine safe for pregnant diabetics  -  Apr 20, 2007
Scientific AmericanNEW YORK (Reuters Health) - The use of insulin glargine, a man-made type of insulin, for diabetes during pregnancy does not increase the risk of

Traditional Insulin Compares Well Against Analogs  -  Apr 18, 2007
MedPage Today,Explain to patients who ask that insulin NPH and the newer insulin analogs insulin glargine and insulin determir are long-acting insulins designed to

Insulin Analogs or Premixed Insulin Analogs in Combination With ...  -  Apr 17, 2007
Medscape (subscription)Comparison of the pharmacokinetics and pharmacodynamics of biphasic insulin aspart and insulin glargine in people with type 2 diabetes. Diabetologia.

New, Old Insulin Drugs Equally Good  -  Apr 18, 2007
WebMD..."Until long-term efficacy and safety data are available, we suggest a cautious approach to therapy with insulin glargine or detemir," write Horvath and

New Data Confirm That Use Of Levemir® Can Limit Weight Gain  -  Apr 23, 2007
Medical News Today (press release),Insulin Detemir Added to Oral Anti-Diabetic Drugs in Type 2 Diabetes Provides Glycemic Control Comparable to Insulin Glargine with Less Weight Gain.

Standard Long-Acting Insulin As Good As Newer Medications  -  Apr 24, 2007
eMaxHealth.com,Newer drugs, insulin analogues such as insulin glargine (trade name Lantus) and insulin detemir (Levemir), have been marketed as an improvement over NPH.

Uncontrolled Type 2 Diabetes Patients More Likely to Start Insulin ...  -  Apr 16, 2007
DG News27.5%, P = .0002) and in the group on 1 or more oral agents plus insulin glargine (66.0% vs. 40.0%, P= .0005). Nearly all subjects who chose insulin

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional